Showing results (101-110 of 274) with videos related to

Sort By:
Pageof 28
Cancer Treatment Reviews|March 24, 2020
Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisationAvani Athauda, Caroline Fong, David K Lau, et al.
Expert Review of Gastroenterology & Hepatology|August 17, 2021
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinomaShubham Gupta, Sikandar Khan, Michal Kawka, et al.
Cancer Discovery|September 1, 2018
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical TrialKhurum H Khan, David Cunningham, Benjamin Werner, et al.
BMC Cancer|August 2, 2012
Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastasesEliza A Hawkes, George Ladas, David Cunningham, et al.
BMC Gastroenterology|May 7, 2020
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancerDavid Gómez-Ulloa, Mayur Amonkar, Smita Kothari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerEliza Hawkes, Alicia F C Okines, Demetris Papamichael, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2020
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)Avani Athauda, Matthew Nankivell, Ruth E Langley, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 14, 2025
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinomaKeiji Sugiyama, Sacheen Kumar, Asif Chaudry, et al.
Cancers|March 15, 2020
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE StudyIan Chau, Marwan Fakih, Pilar García-Alfonso, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2018
Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trialsIan Chau, Charles S Fuchs, Atsushi Ohtsu, et al.
Pageof 28